Close
AI in Healthcare & Pharma Summit Boston 2026

LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory

LexaGene Holdings, Inc. , a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced  it has an agreement...

Bosch introduces entry-level Pack 102 flow wrapper with robotic integration at IBIE

At the International Baking Industry Expo (IBIE) 2019, Bosch Packaging Technology will introduce its entry-level Pack 102 horizontal flow wrapper using a Fanuc Scara...

Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694

Zenith Capital Corp  announced that Zenith Epigenetics Ltd , a wholly-owned subsidiary of Zenith Capital, has entered into a licensing agreement with Newsoara BioPharma...

Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China

Aucta Pharmaceuticals, Inc , a technology based company focusing on the development and commercialization of Branded Specialty Products,  announced that the Company has entered...

Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial

Caladrius Biosciences, Inc, a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular and autoimmune diseases, and Cognate BioServices, Inc....

Omeros and Lonza Enter Long-Term Manufacturing Agreement for Commercial Supply of Narsoplimab

Omeros Corporation  and Lonza  announced a long-term manufacturing agreement for commercial production of narsoplimab, Omeros’ lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2...

ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and SOPHiA GENETICS, a leader...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...